Literature DB >> 8258319

Allergy-associated I epsilon and Ec epsilon receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element.

I Köhler1, E P Rieber.   

Abstract

Interleukin-4 (IL-4) has important regulatory functions in the immune system, particularly in the generation of immunoglobulin E, the principal mediator of allergic responses. The molecular basis of IL-4 action has remained elusive so far. Here we report on a novel human transcription factor, termed nuclear factor IL-4 (NF-IL4), which is posttranslationally activated by IL-4 in lymphoid and monocytic cells. Homologous binding sequences for NF-IL4 were identified in the promoter regions of the IL-4 controlled CD23b and I epsilon genes. We defined a palindromic 9-bp consensus sequence (5'-TYCYRRGAA-3') as IL-4-responsive element (IL-4RE). Point mutation analysis of the CD23b promoter showed that binding of NF-IL4 to the IL-4RE is essential for the initiation of gene transcription in response to IL-4. NF-IL4 was not activated by Ca2+ ionophore, phorbol ester and cAMP either alone or in combination suggesting a non classical pathway for IL-4 signal transduction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258319     DOI: 10.1002/eji.1830231204

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.

Authors:  Frank D Vladich; Susan M Brazille; Debra Stern; Michael L Peck; Raffaella Ghittoni; Donata Vercelli
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

Review 2.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

3.  Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells.

Authors:  R Moriggl; S Berchtold; K Friedrich; G J Standke; W Kammer; M Heim; M Wissler; E Stöcklin; F Gouilleux; B Groner
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 4.  Signal transduction and activation of gene transcription by interferons.

Authors:  K C Gilmour; N C Reich
Journal:  Gene Expr       Date:  1995

5.  Transcriptional repression of Stat6-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching.

Authors:  M B Harris; C C Chang; M T Berton; N N Danial; J Zhang; D Kuehner; B H Ye; M Kvatyuk; P P Pandolfi; G Cattoretti; R Dalla-Favera; P B Rothman
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling.

Authors:  Elisabeth Maier; Daniel Hebenstreit; Gernot Posselt; Peter Hammerl; Albert Duschl; Jutta Horejs-Hoeck
Journal:  J Biol Chem       Date:  2010-10-27       Impact factor: 5.157

7.  Interleukin 4 signals through two related pathways.

Authors:  A Pernis; B Witthuhn; A D Keegan; K Nelms; E Garfein; J N Ihle; W E Paul; J H Pierce; P Rothman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation.

Authors:  A D Keegan; J A Johnston; P J Tortolani; L J McReynolds; C Kinzer; J J O'Shea; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  A novel IL-4 responsive element of the E alpha MHC class II promoter that binds to an inducible factor.

Authors:  A Kretsovali; J Papamatheakis
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

10.  Human 15-lipoxygenase gene promoter: analysis and identification of DNA binding sites for IL-13-induced regulatory factors in monocytes.

Authors:  U Kelavkar; S Wang; A Montero; J Murtagh; K Shah; K Badr
Journal:  Mol Biol Rep       Date:  1998-07       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.